STOK - SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Stoke Therapeutics Inc. (NASDAQ: STOK) and Encourages Investors to Contact the Firm | Benzinga
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Stoke Therapeutics, Inc. (NASDAQ:STOK) ("Stoke") on behalf of the company's investors.
Since July 2023, shares of Stoke's common stock have declined in value from a trading price of over $10.00 per share to a current trading price of less than $5.00 per share, a cumulative decline of over $5.00 per share, ...
STOK) and Encourages Investors to Contact the Firm>Full story available on Benzinga.com